Description: Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company's products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. It distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. The company was founded in 2003 and is based in Pisa, Italy.
Home Page: www.pharmanutra.it
Via delle Lenze 216/B
Pisa,
PI
56122
Italy
Phone:
39 05 07 84 65 00
Officers
| Name | Title |
|---|---|
| Mr. Andrea Lacorte | Chairman & Gen. Director |
| Mr. Roberto Lacorte | Vice Chairman, MD & VP |
| Mr. Carlo Volpi | Delegate Advisor, COO & Exec. Director |
| Mr. Germano Tarantino | Scientific Director & Exec. Director |
Exchange: MI
Country: IT
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 38.2209 |
| Price-to-Book MRQ: | 12.4997 |
| Price-to-Sales TTM: | 7.6923 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 86 |